Summary
Market Segment as follows:
By Type
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
By Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
By Company
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Ioversol 34% Injectable Solution (Optiray 160)
1.1.2.2 Ioversol 51% Injectable Solution (Optiray 240)
1.1.2.3 Ioversol 64% Injectable Solution (Optiray 300)
1.1.2.4 Ioversol 68% Injectable Solution (Optiray 320)
1.1.2.5 Ioversol 74% Injectable Solution (Optiray 350)
1.1.3 Market by Application
1.1.3.1 X-ray
1.1.3.2 CT Scan
1.1.3.3 Brain Disorders
1.1.3.4 Blood Vessel Disorders
1.1.3.5 Heart Disorders
1.1.3.6 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Liebel-Flarsheim Company LLC
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Guerbet
6.3 Jiangsu Hengrui Medicine Co
6.4 Mallinckrodt Pharmaceuticals
6.5 Ultraject
6.6 China Resources Pharmaceutical (Shanghai) Co
6.7 HB Ocean
6.8 Novalek Pharmaceuticals Pvt. Ltd
6.9 Stellence Pharmscience Pvt. Ltd
6.10 A.S. Joshi & Company
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Ioversol 34% Injectable Solution (Optiray 160) Market Size and CAGR 2013-2018 (Million USD)
Figure Ioversol 34% Injectable Solution (Optiray 160) Market Size and CAGR 2013-2018 (Volume)
Figure Ioversol 34% Injectable Solution (Optiray 160) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ioversol 34% Injectable Solution (Optiray 160) Market Forecast and CAGR 2019-2025 (Volume)
Figure Ioversol 51% Injectable Solution (Optiray 240) Market Size and CAGR 2013-2018 (Million USD)
Figure Ioversol 51% Injectable Solution (Optiray 240) Market Size and CAGR 2013-2018 (Volume)
Figure Ioversol 51% Injectable Solution (Optiray 240) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ioversol 51% Injectable Solution (Optiray 240) Market Forecast and CAGR 2019-2025 (Volume)
Figure Ioversol 64% Injectable Solution (Optiray 300) Market Size and CAGR 2013-2018 (Million USD)
Figure Ioversol 64% Injectable Solution (Optiray 300) Market Size and CAGR 2013-2018 (Volume)
Figure Ioversol 64% Injectable Solution (Optiray 300) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ioversol 64% Injectable Solution (Optiray 300) Market Forecast and CAGR 2019-2025 (Volume)
Figure Ioversol 68% Injectable Solution (Optiray 320) Market Size and CAGR 2013-2018 (Million USD)
Figure Ioversol 68% Injectable Solution (Optiray 320) Market Size and CAGR 2013-2018 (Volume)
Figure Ioversol 68% Injectable Solution (Optiray 320) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ioversol 68% Injectable Solution (Optiray 320) Market Forecast and CAGR 2019-2025 (Volume)
Figure Ioversol 74% Injectable Solution (Optiray 350) Market Size and CAGR 2013-2018 (Million USD)
Figure Ioversol 74% Injectable Solution (Optiray 350) Market Size and CAGR 2013-2018 (Volume)
Figure Ioversol 74% Injectable Solution (Optiray 350) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ioversol 74% Injectable Solution (Optiray 350) Market Forecast and CAGR 2019-2025 (Volume)
Figure X-ray Market Size and CAGR 2013-2018 (Million USD)
Figure X-ray Market Size and CAGR 2013-2018 (Volume)
Figure X-ray Market Forecast and CAGR 2019-2025 (Million USD)
Figure X-ray Market Forecast and CAGR 2019-2025 (Volume)
Figure CT Scan Market Size and CAGR 2013-2018 (Million USD)
Figure CT Scan Market Size and CAGR 2013-2018 (Volume)
Figure CT Scan Market Forecast and CAGR 2019-2025 (Million USD)
Figure CT Scan Market Forecast and CAGR 2019-2025 (Volume)
Figure Brain Disorders Market Size and CAGR 2013-2018 (Million USD)
Figure Brain Disorders Market Size and CAGR 2013-2018 (Volume)
Figure Brain Disorders Market Forecast and CAGR 2019-2025 (Million USD)
Figure Brain Disorders Market Forecast and CAGR 2019-2025 (Volume)
Figure Blood Vessel Disorders Market Size and CAGR 2013-2018 (Million USD)
Figure Blood Vessel Disorders Market Size and CAGR 2013-2018 (Volume)
Figure Blood Vessel Disorders Market Forecast and CAGR 2019-2025 (Million USD)
Figure Blood Vessel Disorders Market Forecast and CAGR 2019-2025 (Volume)
Figure Heart Disorders Market Size and CAGR 2013-2018 (Million USD)
Figure Heart Disorders Market Size and CAGR 2013-2018 (Volume)
Figure Heart Disorders Market Forecast and CAGR 2019-2025 (Million USD)
Figure Heart Disorders Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Ioversol Market Size and CAGR 2013-2017 (Million USD)
Figure Global Ioversol Market Size and CAGR 2013-2017 (Volume)
Figure Global Ioversol Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Ioversol Market Forecast and CAGR 2019-2025 (Volume)
Figure China Ioversol Market Size and CAGR 2013-2017 (Million USD)
Figure China Ioversol Market Size and CAGR 2013-2017 (Volume)
Figure China Ioversol Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Ioversol Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Ioversol SWOT List
Figure Ioversol Porter's Five Forces
